--- SMARTEST Trial---

Condition:   Mesothelioma, Malignant Interventions:   Drug: Cyclophosphamide;   Drug: Tremelimumab;   Drug: Durvalumab Sponsors:   University Health Network, Toronto;   OICR Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials